Article requires registration
Sweden: Covid-19 Karolinska Institutet on Track to Produce Vaccine Against Coronavirus
Researchers at Karolinska Institutet announced they are on track to produce a vaccine against the new coronavirus, Sars-CoV-2. Several vaccine candidates are currently available in the freezers at the Department of Laboratory Medicine and the first animal studies are slated to begin at the end of March, according to Professor and Head of Department Matti Sällberg who is leading the effort together with virus researcher and Professor Ali Mirazimi and researcher Gustaf Ahlén.
Solna/Sweden — Professor and Head of Department Matti Sällberg at Karolinska Institutet outlines the steps necessary to develop a vaccine against the coronavirus.
What is the status of the vaccine development?
We have several vaccine candidates ready in the freezers and week 13 we will begin the first trials in animals. We will start by testing two vaccine candidates in rabbits to see if they are able to trigger the immune response we are hoping for. These vaccine candidates target those parts of the virus that are genetically stable and that we therefore hope will give protection against other types of coronaviruses as well. Instead of just focusing on finding a vaccine against Sars-CoV-2, we are trying to think one step ahead and find a vaccine that could be used against different types of coronaviruses. That would mean that the next time there is a coronavirus outbreak — and it will happen again — you have an effective vaccine available and don’t need to start all over again.